ReviewFrontiers in cardiovascular medicine2026
Reversal of left ventricular hypertrophy with sacubitril/valsartan vs. standard antihypertensive agents in hypertension: a systematic review and network meta-analysis.
Weizhi Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.